GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (HAM:BBZA) » Definitions » Cyclically Adjusted PB Ratio

BB Biotech AG (HAM:BBZA) Cyclically Adjusted PB Ratio : (As of Jul. 19, 2025)


View and export this data going back to 2008. Start your Free Trial

What is BB Biotech AG Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


BB Biotech AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted PB Ratio Chart

BB Biotech AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.98 1.22 1.14 0.58

BB Biotech AG Quarterly Data
Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 1.09 0.67 0.58 0.50

Competitive Comparison of BB Biotech AG's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.


;
;

BB Biotech AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=37.219/107.7224*107.7224
=37.219

Current CPI (Mar. 2025) = 107.7224.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201209 100.474 101.392 106.747
201212 89.853 100.968 95.864
201303 96.554 101.221 102.755
201306 115.184 101.466 122.286
201309 23.184 101.336 24.645
201312 25.376 101.036 27.055
201403 25.282 101.224 26.905
201406 27.660 101.517 29.351
201409 33.797 101.247 35.959
201412 51.480 100.704 55.068
201503 62.074 100.339 66.642
201506 68.801 100.464 73.772
201509 57.035 99.785 61.572
201512 65.895 99.386 71.422
201603 42.928 99.475 46.487
201606 43.651 100.088 46.981
201609 50.051 99.604 54.130
201612 50.424 99.380 54.657
201703 54.383 100.040 58.559
201706 55.243 100.285 59.340
201712 54.685 100.213 58.783
201812 46.141 100.906 49.258
201912 56.097 101.063 59.793
202012 64.928 100.241 69.774
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202112 57.062 101.776 60.396
202203 48.928 103.205 51.070
202206 44.678 104.783 45.931
202209 0.000 104.835 0.000
202212 49.628 104.666 51.077
202303 41.879 106.245 42.461
202306 42.287 106.576 42.742
202309 42.048 106.570 42.503
202312 44.916 106.461 45.448
202403 46.702 107.355 46.862
202406 45.235 107.991 45.123
202409 43.237 107.468 43.339
202412 44.718 107.128 44.966
202503 37.219 107.722 37.219

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BB Biotech AG  (HAM:BBZA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BB Biotech AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines